Shavini Fernando (G’18) is the Founder and CEO of OxiWear, a health tech company transforming patient safety through continuous oxygen measurements. After being diagnosed with severe pulmonary hypertension and surviving silent hypoxia and multiple cardiac arrests, Shavini turned her personal battle into a mission to protect others from undetected oxygen drops. Under her leadership, OxiWear secured FDA clearance for its innovative wearable device, designed to reduce hospital readmissions and empower patients to live independently. A former video game and VR developer, she holds degrees from Georgetown, Edith Cowan, and Portsmouth Universities. Shavini’s work has earned the Washington Business Journal’s 40 Under 40 and Women Who Mean Business honors, Georgetown University’s Exceptional Master’s Student Award, and the American Heart Association’s 2025 Impact with Heart Award, She is passionate about advancing patient-led innovation and creating meaningful social impact worldwide.

OxiWear is a health tech ear-wearable company dedicated to minimizing patient vulnerability to low blood oxygen through continuous oxygen measurements and low-oxygen alerts. Designed as a discreet, ear-worn device, OxiWear empowers individuals at risk—such as those with pulmonary hypertension, cardiovascular and respiratory conditions, or athletes training at altitude—to proactively manage their oxygen levels, enhancing safety and peace of mind. With FDA clearance as a prescription medical device, OxiWear’s innovative solution aims to improve quality of life and clinical outcomes while reducing healthcare costs by preventing emergency interventions. In recognition of its breakthrough contributions to medical technology, OxiWear was recently awarded the 2025 Medical Wearable of the Year by Med Tech World in Dubai, underscoring its leadership in advancing wearable health solutions on a global stage.